PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy

The mineralocorticoid receptor (MR) antagonists PF 03882845 and eplerenone were evaluated for renal protection against aldosterone mediated renal disease in uninephrectomized Sprague Dawley (SD) rats maintained on a high salt diet and receiving aldosterone by osmotic mini pump for 27 days. Serum K+...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Stephen eOrena, Tristan eMaurer, Rena eEudy, Li eShe, Darla eDash, Paula eLoria, Mary Ellen eBanker, Vincent eBernardo, Meera eTugnait, Carlin eOkerberg, Jessie eQian, Carine M Boustany-Kari
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2013-10-01
سلاسل:	Frontiers in Pharmacology
الموضوعات:	Albuminuria Aldosterone Hyperkalemia Chronic Kidney Disease mineralocorticoid receptor diabetic nephropathy
الوصول للمادة أونلاين:	http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00115/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!